盛禾生物-B公布中期业绩 净亏损3819.9万元 同比增长5.88%

Group 1 - The company Shenghe Biotechnology-B (02898) reported its interim results for 2025, showing other income of 5.035 million, which represents a year-on-year increase of 182.55% [1] - The company recorded a net loss of 38.199 million, reflecting a year-on-year increase of 5.88% [1] - The loss per share was reported at 0.25 yuan [1]